The number of cannabidiol-based pharmaceutical products in the pipeline continues to grow, with the US Food and Drug Administration (FDA) recently granting yet another orphan drug designation for CBD.
The agency’s orphan drug programme is intended to encourage development of treatments for rare ailments affecting fewer than 200,000 people in the US (termed “orphan diseases”) or in other circumstances where it is unlikely that the cost of development will be recovered.
Created by the 1983 Orphan Drug Act, the designation does not permit products to be sold – an FDA marketing approval is still required for that – but it does allow manufacturers to benefit from tax breaks, reduced fees and other financial advantages, such as seven years’ protection from competition.
Before joining ECigIntelligence in early 2014 as one of its first employees, Barnaby had a 30-year career as a reporter and editor for newspapers, magazines and online services, working in Canada, the US and the Middle East as well as his current British location. He has edited publications covering fields including technology and the advertising industry, and was launch editor of the first large daily online news service in the British regional media. Barnaby also writes on classical music and film for a number of publications. Barnaby manages the editorial and reporting teams and works closely with the analyst teams, to ensure that all content meets high standards of quality and relevance. He also writes for the site occasionally, mostly on science-related issues, and is a member of the Association of British Science Writers.
Our Key Benefits
The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.
CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.
Stay informed of any legal and market change in the sector that impacts your organisation
Maximise resources by getting market and legal data analysis daily in one place
Make smart decisions by understanding how the regulatory and market landscape evolves
Anticipate risks in your decisions by monitoring regulatory changes that impact your organization
Want the full analysis? Let's talk
We share insights with professionals we’re in contact with. Let us know a bit about your interest.
"*" indicates required fields
Start your FREE trial
Get 7 days of access to industry updates through our news analysis and regulatory alerts
LATEST ALERTS
